Trial Profile
An Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Brexanolone in the Treatment of Adult Participants With Tinnitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2023
Price :
$35
*
At a glance
- Drugs Brexanolone (Primary)
- Indications Tinnitus
- Focus Adverse reactions
- Sponsors Sage Therapeutics
- 21 Dec 2023 Status changed from active, no longer recruiting to completed.
- 14 Dec 2023 Status changed from recruiting to active, no longer recruiting.
- 29 Sep 2023 Planned End Date changed from 1 Oct 2023 to 1 Apr 2024.